The met protooncogene, a member of the tyrosine kinase receptor family, is widely expressed in adult and embryonic tissues as well as in primary cells and cell lines (1) (2) (3) (4) . The ligand for Met is hepatocyte growth factor/scatter factor (HGF/SF) (5, 6) . HGF, a mitogen for hepatocytes as well as a wide variety of epithelial and endothelial cells (7) , is identical to scatter factor (SF), an activity that disperses epithelial cells in vitro and promotes cell movement (8) . HGF/SF has been shown to promote chemotaxis, chemokinesis, and invasiveness in vitro (9, 10) ; to induce blood vessel formation and contribute to tumor angiogenesis (11, 12) ; and to stimulate endothelial cell migration and capillarylike tube formation (13) in vitro. We have recently shown that Met-HGF/SF mediates mesenchymal to epithelial transition (14) .
These pleiotropic effects of HGF/SF could contribute to tumor invasion and metastasis. While tumorigenic and metastatic cells are highly mitogenic, metastatic cells additionally exhibit increased attachment to extracellular matrix, enhanced proteolysis of basement membranes, increased motility, and the ability to colonize target organs (15) . Several oncogenes including src, ras (16) , and neu (17) confer increased tumorigenic and metastatic properties to NIH 3T3 cells in nude mice.
met is frequently amplified and overexpressed in spontaneous NIH 3T3 cell transformants (18) , and overexpression of met in NIH 3T3 cells directly leads to cell transformation and tumorigenicity (1) . We have shown that NIH 3T3 cells express murine HGF/SF (HGF/SFmu) endogenously and that, with ectopic murine Met expression, these cells become tumorigenic by an autocrine mechanism (19, 20) . We have recently reported that Met autocrine activation also may play a role in human soft tissue sarcomas (3 (19, 20) . NIH 3T3 cells transformed by ras (gift of Donald Blair, NCI-FCRDC) or src (21) were used as controls. A rare tumorigenic clone of Methu-transfected NIH 3T3 cells, MT cells, are transformed by a nonautocrine mechanism and were used as controls for the autocrine-transformed Metmu and HMH cells (14) . All cells were maintained as described (19, 20) . C28 anti-peptide antibody was raised in rabbits by immunization with the C-terminal 28 amino acids of Methu (2) . The SP260 anti-peptide antibody is a rabbit antiserum directed against the C-terminal 21 amino acids of Metmu (5) . A3.1.2 is a monoclonal antibody against human recombinant HGF (IgG, subclass G2a; a gift from T. Nakamura, Osaka). Immunoprecipitation of Met and HGF/SF was carried out as described (19, 20) .
Experimental and Spontaneous Metastasis. All test cells were washed twice and resuspended in 0.1 ml of serum-free medium (DMEM; GIBCO) prior to injection. For experimental metastasis assays, the cells were injected intravenously into the tail vein ofweanling athymic (BALB/c nu/nu), NFS, BALB/c or triple-deficient (NIH bg-nu-Xid, TDM) (HarlanSprague-Dawley) mice. For spontaneous metastasis assays, cells were injected subcutaneously into the back of athymic mice. Tumor formation was monitored twice weekly. Fastgrowing tumors at the site of inoculation (15-20 mm in size) were surgically removed. Spontaneous metastasis assays were also performed by injecting cells into the mammary fat pad (22) . For each assay, major organs (lung, liver, spleen, kidney, stomach, colon, brain, and skin) were examined as described below for the development of metastases. Animals were sacrificed when they appeared distressed; those remaining after 12 weeks were sacrificed and examined for tumors. Coflagenase Secretion. The ability to proteolytically degrade basement membrane collagen has been correlated with metastatic potential (15, 24) . We compared the collagenase activity of parental NIH 3T3, HMH, Metmu, MT, and TprMet cells. These analyses showed that enhanced type I and IV collagenase activities were present in HMH, Metmu, and Tpr-Met cells (Fig. 1) . Comparable results were obtained using denatured collagen (data not shown). The collagenase levels were also high in the MT tumor cells (data not shown), even though their invasive activity was stimulated only by exogenous HGF/SFhU (Table 1 ). These data imply that increased collagenase secretion may be required for invasiveness but, by itself, is not sufficient to induce the invasive phenotype. Furthermore, while the parental HMH cells expressed high levels of collagenase compared to control NIH 3T3 cells, primary and secondary HMH tumor cell explants expressed higher levels (Fig. 1) , which correlated with a significant increase in spontaneous in vitro invasiveness (Table 1) . Experimental Metastasis. Met-HGF/SF autocrine signaling in NIH 3T3 cells stimulates invasive migration in vitro and protease production ( Fig. 1 and Table 1 ). To determine whether these activities paralleled metastatic activity in vivo, we tested whether HMH, Metmu, MT, and Tpr-Met cells would colonize the lung of nude mice. Histopathological analyses revealed that parental Metmu cells efficiently induced lung metastases ( Table 2) . Parental HMH cells were poorly active in this assay, but primary and secondary tumor cell explants, which express much higher levels of Methu and HGF/SFhU (19, 20) , produced lung tumors within 3 weeks. The explanted lung tumor cells generated by HMH primary tumor cells exhibited increased levels of Methu and HGF/ SFhu ( Fig. 2 A and B, lanes 3-6) , similar to the enhanced levels of expression found in secondary tumor explants in nude mouse tumor assays (20) . Met was also abundantly expressed in lung tumor cell explants generated by parental Metmu cells (Fig. 2C, lanes 1 and 2) . Interestingly, two of the animals injected with control Neor NIH 3T3 cells developed lung tumors that expressed high levels of endogenous Metmu (Fig. 2C, lanes 4 and 5) . Amplification of endogenous Met occurs frequently in spontaneous NIH 3T3 cell transformants (18) , and Methu is also amplified in human sarcomas (3) . Here, we show that endogenous Metmu amplification has occurred spontaneously to induce experimental metastasis. The TprMet cells were also very efficient at populating the lung, whereas MT cells, which are highly tumorigenic in nude mice (data not shown), did not efficiently colonize the lung (Table  2) .
We also injected HMH, Metmu, and Tpr-Met cells into the tail vein of immune competent BALB/c and NFS mice, as well as into triple-immunodeficient mice ( (Table 3 and Fig. 3 A and B) showed greatly enhanced metastatic activity. Interestingly, at low cell inoculation densities, the Metmu cells also metastasized to the parotid and sublingual salivary gland and obliterated the entire submandibular gland (Fig. 3D) . The Metmu cells also metastasized to the retroperitoneum (Fig. 3F) , while HMH cells could colonize and invade both the heart (Fig. 3C ) and the diaphragm (Fig. 3E) . The MT cells did not produce metastases in subcutaneous assays. NIH 3T3 cells transformed by activated ras or src oncogenes are known to generate efficient lung metastasis (18) and served as a positive control (Table 3) .
We also tested HMH, Metmu, and Tpr-Met cells for metastatic activity after inoculating cells into the mammary fat pad of nude mice. All three cell types induced spontaneous lung metastases (Table 3) but again, the primary and tertiary athymic nude mouse tumor explants were more active in this assay.
DISCUSSION
Tumor invasion and metastasis are complex, multistep processes that are associated with only a small percentage of primary tumor cells. For tumor cells to metastasize, they must acquire the ability to alternately penetrate and exit through the walls of primary and target organs, as well as the vascular and/or lymphatic circulatory systems, and undergo the cell proliferation and angiogenesis required for colonization (15) . Gene products that regulate the processes of cell adhesion, activation and secretion of proteases, cell motility, cell growth, and angiogenesis could contribute to the metastatic potential. Many of these phenotypes have been associated with Met-HGF/SF-mediated signal transduction, suggesting that Met and HGF/SF could play a role in metastasis.
Stoker (25) first proposed that HGF/SF may be involved in tumor invasion and metastasis, since the ligand elicits scattering and motility in epithelial cells in vitro. HGF/SF and other cell motility factors are postulated to be involved in inflammatory reactions, tissue repair, and interactions in the immune system (8) . Here, we show that Tpr-Met cells grow (19, 20) . In these studies, we show that the same autocrine interaction in NIH 3T3 cells HGF/SF serves as a paracrine effector of mesenchymalepithelial interactions (8, 27) . When epithelial cells scatter in vitro, they resemble fibroblasts in culture (25) , and there are examples of cells and tissues that could display this phenotype. Thus, HGF/SF has been detected in various carcinoma cell lines (28, 29) , and epithelial carcinoma cell lines expressing both Met and HGF/SF grow as single cells but grow as colonies when HGF/SF signaling is blocked (30) . Further, we recently demonstrated that autocrine Met-HGF/SF expression can mediate mesenchymal to epithelial cell transition (14) . These observations suggest the possibility that alternating between high and low levels of Met and/or HGF/SF expression could play a role in the selection for phenotypes of migration and colonization necessary for metastasis.
Met-HGF/SF autocrine expression in NIH 3T3 cells increases not only cell motility but also type I and type IV collagenase activities, two enzymes that are essential for invasiveness. Similarly, HGF/SF stimulates bovine brain endothelial cell motility and increases the secretion of plasminogen activator activity (13) . Our studies suggest that motility and protease production can be independently regulated, since the MT cells that overexpress only Methu produce elevated levels of collagenase but are not invasive in vitro in the absence of HGF/SF (Table 1) .
We have shown that with increasing passage of HMH tumors, there is a concomitant increase in the levels of HGF/SF and Met protein expression (19, 20) . Here we show that the level of Met and HGF/SF expression directly correlates with invasiveness activity in vitro (Table 1) , collagenase activity (Fig. 2) , and enhanced experimental ( Table  2 ) and spontaneous (Table 3) What is the mechanism of Met-induced metastasis? The Met signal transduction pathway has been linked with src and ras activation (31, 32) , and, perhaps, it is through these oncogenes that Met functions to confer a metastatic phenotype (16) . Further, an engineered secreted form of basic fibroblast growth factor (33) and an activated human c-erb B2/neu oncogene (17) have been shown to increase invasiveness in vitro, implying that other ligands and receptors have this activity. To our knowledge, Met-HGF/SF is the first example of an unmodified receptor-ligand pair mediating a metastatic phenotype, implying that the abnormal process of metastasis can proceed through a conventional signal transduction pathway but in an inappropriate cell background. met was first isolated as a transforming gene, tpr-met, from MNNG-treated HOS cells, and its trivial name was derived from N-methyl-N'-nitro-N-nitrosoguanidine (34), but from our present studies, metastasis is also appropriate.
